Startseite
Impressum
Datenschutz
 
 
  NEW ON THE MARKET
 

Antiarrhythmic drug dronedarone (MULTAQ) for atrial fibrillation

 
  REVIEW
 

Fat-modified diet for cardiovascular prevention - what is proven?

 
  IN BRIEF
 

UMCKALOABO - patent for manufacturing revoked

Inhibitor ranibizumab (LUCENTIS): erratum

 
  SIDE EFFECTS

Finally: appetite suppressant sibutramine (REDUCTIL) off market

Progressive multifocal leukencephalopathy (PML) due to natalizumab (TYSABRI)

 
© arznei-telegramm 2/2010